349 related articles for article (PubMed ID: 24910192)
1. Controlling molecular transport and sustained drug release in lipid-based liquid crystalline mesophases.
Zabara A; Mezzenga R
J Control Release; 2014 Aug; 188():31-43. PubMed ID: 24910192
[TBL] [Abstract][Full Text] [Related]
2. Lipid polymorphism in lyotropic liquid crystals for triggered release of bioactives.
Garti N; Libster D; Aserin A
Food Funct; 2012 Jul; 3(7):700-13. PubMed ID: 22592749
[TBL] [Abstract][Full Text] [Related]
3. Oil and drug control the release rate from lyotropic liquid crystals.
Martiel I; Baumann N; Vallooran JJ; Bergfreund J; Sagalowicz L; Mezzenga R
J Control Release; 2015 Apr; 204():78-84. PubMed ID: 25744826
[TBL] [Abstract][Full Text] [Related]
4. Bicontinuous cubic liquid crystals as sustained delivery systems for peptides and proteins.
Rizwan SB; Boyd BJ; Rades T; Hook S
Expert Opin Drug Deliv; 2010 Oct; 7(10):1133-44. PubMed ID: 20858165
[TBL] [Abstract][Full Text] [Related]
5. Cubic and hexagonal liquid crystals as drug delivery systems.
Chen Y; Ma P; Gui S
Biomed Res Int; 2014; 2014():815981. PubMed ID: 24995330
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the link between self-assembled mesophase structure and drug release.
Phan S; Fong WK; Kirby N; Hanley T; Boyd BJ
Int J Pharm; 2011 Dec; 421(1):176-82. PubMed ID: 21963475
[TBL] [Abstract][Full Text] [Related]
7. Tuning in-meso-crystallized lysozyme polymorphism by lyotropic liquid crystal symmetry.
Zabara A; Amar-Yuli I; Mezzenga R
Langmuir; 2011 May; 27(10):6418-25. PubMed ID: 21506575
[TBL] [Abstract][Full Text] [Related]
8. Recent patents on nonlamellar liquid crystalline lipid phases in drug delivery.
Koynova R; Tenchov B
Recent Pat Drug Deliv Formul; 2013 Dec; 7(3):165-73. PubMed ID: 23829393
[TBL] [Abstract][Full Text] [Related]
9. Lyotropic liquid crystalline phases: Drug delivery and biomedical applications.
Chavda VP; Dyawanapelly S; Dawre S; Ferreira-Faria I; Bezbaruah R; Rani Gogoi N; Kolimi P; Dave DJ; Paiva-Santos AC; Vora LK
Int J Pharm; 2023 Nov; 647():123546. PubMed ID: 37884213
[TBL] [Abstract][Full Text] [Related]
10. Lyotropic liquid crystal systems in drug delivery.
Guo C; Wang J; Cao F; Lee RJ; Zhai G
Drug Discov Today; 2010 Dec; 15(23-24):1032-40. PubMed ID: 20934534
[TBL] [Abstract][Full Text] [Related]
11. Lyotropic Cubic Phases for Drug Delivery: Diffusion and Sustained Release from the Mesophase Evaluated by Electrochemical Methods.
Nazaruk E; Miszta P; Filipek S; Górecka E; Landau EM; Bilewicz R
Langmuir; 2015 Nov; 31(46):12753-61. PubMed ID: 26513537
[TBL] [Abstract][Full Text] [Related]
12. Lyotropic liquid crystals for parenteral drug delivery.
Chavda VP; Dawre S; Pandya A; Vora LK; Modh DH; Shah V; Dave DJ; Patravale V
J Control Release; 2022 Sep; 349():533-549. PubMed ID: 35792188
[TBL] [Abstract][Full Text] [Related]
13. Phytantriol based smart nano-carriers for drug delivery applications.
Akbar S; Anwar A; Ayish A; Elliott JM; Squires AM
Eur J Pharm Sci; 2017 Apr; 101():31-42. PubMed ID: 28137471
[TBL] [Abstract][Full Text] [Related]
14. Tailoring liquid crystalline lipid nanomaterials for controlled release of macromolecules.
Bisset NB; Boyd BJ; Dong YD
Int J Pharm; 2015 Nov; 495(1):241-248. PubMed ID: 26319637
[TBL] [Abstract][Full Text] [Related]
15. Interactions of biomacromolecules with reverse hexagonal liquid crystals: drug delivery and crystallization applications.
Libster D; Aserin A; Garti N
J Colloid Interface Sci; 2011 Apr; 356(2):375-86. PubMed ID: 21315366
[TBL] [Abstract][Full Text] [Related]
16. Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery.
Angelova A; Angelov B; Mutafchieva R; Lesieur S; Couvreur P
Acc Chem Res; 2011 Feb; 44(2):147-56. PubMed ID: 21189042
[TBL] [Abstract][Full Text] [Related]
17. Controlling anisotropic drug diffusion in lipid-Fe3O4 nanoparticle hybrid mesophases by magnetic alignment.
Vallooran JJ; Negrini R; Mezzenga R
Langmuir; 2013 Jan; 29(4):999-1004. PubMed ID: 23302008
[TBL] [Abstract][Full Text] [Related]
18. Formulation and characterization of a liquid crystalline hexagonal mesophase region of phosphatidylcholine, sorbitan monooleate, and tocopherol acetate for sustained delivery of leuprolide acetate.
Báez-Santos YM; Otte A; Mun EA; Soh BK; Song CG; Lee YN; Park K
Int J Pharm; 2016 Nov; 514(1):314-321. PubMed ID: 27863678
[TBL] [Abstract][Full Text] [Related]
19. External manipulation of nanostructure in photoresponsive lipid depot matrix to control and predict drug release in vivo.
Fong WK; Hanley TL; Thierry B; Hawley A; Boyd BJ; Landersdorfer CB
J Control Release; 2016 Apr; 228():67-73. PubMed ID: 26924351
[TBL] [Abstract][Full Text] [Related]
20. Cubosomes as Carriers for MRI Contrast Agents.
Alcaraz N; Boyd BJ
Curr Med Chem; 2017; 24(5):470-482. PubMed ID: 27538694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
